Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (361-370 of 682) with videos related to

Pageof 69
Sort By:
Journal of Periodontology|September 19, 2023
An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept studySrinivas Sulugodu Ramachandra, Fekade Bruck Sime, Saiyuri Naicker, et al.
International Journal of Pharmaceutics|February 4, 2021
PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral deliveryAun Raza, Jared A Miles, Fekade Bruck Sime, et al.
The Journal of Antimicrobial Chemotherapy|December 13, 2024
Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2024
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2022
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection modelIain J Abbott, Elke van Gorp, Hugh Cottingham, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 29, 2017
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluentSaiyuri Naicker, Yarmarly C Guerra Valero, Jenny L Ordenez Meija, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with SepsisMahipal G Sinnollareddy, Michael S Roberts, Jeffrey Lipman, et al.
Bioanalysis|June 16, 2017
An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluentSuzanne L Parker, Yarmarly C Guerra Valero, Jenny L Ordóñez Mejia, et al.
Critical Care (London, England)|January 31, 2015
The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyKiran Shekar, John F Fraser, Fabio Silvio Taccone, et al.
Anaesthesia and Intensive Care|December 9, 2025
Cefazolin pharmacokinetics during prolonged intermittent kidney replacement therapyJessica H Xu, Sam Salman, David Jr Morgan, et al.
Pageof 69

Showing results (361-370 of 682) with videos related to

Sort By:
Pageof 69
Journal of Periodontology|September 19, 2023
An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept studySrinivas Sulugodu Ramachandra, Fekade Bruck Sime, Saiyuri Naicker, et al.
International Journal of Pharmaceutics|February 4, 2021
PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral deliveryAun Raza, Jared A Miles, Fekade Bruck Sime, et al.
The Journal of Antimicrobial Chemotherapy|December 13, 2024
Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2024
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administrationFionnuala Murray, Okhee Yoo, Samuel Brophy-Williams, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2022
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection modelIain J Abbott, Elke van Gorp, Hugh Cottingham, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 29, 2017
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluentSaiyuri Naicker, Yarmarly C Guerra Valero, Jenny L Ordenez Meija, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with SepsisMahipal G Sinnollareddy, Michael S Roberts, Jeffrey Lipman, et al.
Bioanalysis|June 16, 2017
An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluentSuzanne L Parker, Yarmarly C Guerra Valero, Jenny L Ordóñez Mejia, et al.
Critical Care (London, England)|January 31, 2015
The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyKiran Shekar, John F Fraser, Fabio Silvio Taccone, et al.
Anaesthesia and Intensive Care|December 9, 2025
Cefazolin pharmacokinetics during prolonged intermittent kidney replacement therapyJessica H Xu, Sam Salman, David Jr Morgan, et al.
Pageof 69